Alterity Therapeutics Limited Stock
Stocks
ATH
AU0000043945
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Australian S.E.
13:58:32 25/08/2026 HKT
|
5-day change | 1st Jan Change | ||
| 0.5100 AUD | +0.99% |
|
-3.77% | +27.50% |
| Market Cap | 79.35M 68M 63.72M 58.2M 110M 7.57B 111M 752M 293M 3.82B 298M 291M 12.64B | P/E 2026 * |
-0.39x | P/E 2027 * | -0.39x |
|---|---|---|---|---|---|
| Enterprise Value | 34.1M 29.22M 27.38M 25.01M 47.2M 3.25B 47.67M 323M 126M 1.64B 128M 125M 5.43B | EV / Sales 2026 * |
12.4x | EV / Sales 2027 * | 18.4x |
| Free-Float |
92.1% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Alterity Therapeutics Limited
| 1 day | +0.99% | ||
| 1 week | -3.77% | ||
| Current month | -6.42% | ||
| 1 month | -8.93% | ||
| 3 months | +2.00% | ||
| 6 months | +27.50% | ||
| Current year | +27.50% |
| 1 week | 0.48 |  | 0.52 |
| 1 month | 0.48 | | 0.6 |
| Current year | 0.35 | | 0.78 |
| 1 year | 0.35 | | 0.78 |
| 3 years | 0.1 | | 0.95 |
| 5 years | 0.1 | | 1.7 |
| 10 years | 0.1 | | 20.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Stamler
CEO | Chief Executive Officer | 65 | 07/01/2021 |
Abby Macnish
DFI | Director of Finance/CFO | - | 30/09/2024 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Peter Marks
BRD | Director/Board Member | 70 | 29/07/2005 |
Lawrence Gozlan
BRD | Director/Board Member | 47 | 08/08/2011 |
David Stamler
BRD | Director/Board Member | 65 | 21/11/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 15/6/26 | Free | Director | 1,000,000 | 0.0092% | ||
| 7/1/26 | Expiration | Chief Executive Officer | 91,392,720 | 0.8404% | ||
| 17/9/25 | Expiration | Director | 7,000,000 | 0.1052% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.99% | -3.77% | -15.00% | +45.71% | 78.58M | |
| +1.02% | +4.84% | +4.80% | +24.36% | 51.21B | |
| -0.09% | -2.14% | +492.60% | +537.84% | 45.35B | |
| -0.32% | +8.08% | +37.97% | +18.45% | 42.84B | |
| +1.18% | +1.96% | +21.95% | +89.69% | 42.29B | |
| -2.27% | -5.67% | +14.55% | +50.34% | 32.15B | |
| -0.96% | +4.03% | +31.55% | +136.34% | 17.31B | |
| +0.41% | +1.66% | - | - | 16.55B | |
| +1.12% | +5.83% | +8.37% | +32.33% | 14.84B | |
| -0.31% | +6.61% | +81.37% | +48.53% | 14.25B | |
| Average | +0.10% | +2.28% | +75.35% | +109.29% | 27.69B | |
| Weighted average by Cap. | +0.10% | +2.89% | +105.39% | +135.89% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.74M 2.35M 2.2M 2.01M 3.8M 262M 3.84M 26M 10.12M 132M 10.31M 10.08M 437M | 2.09M 1.79M 1.68M 1.53M 2.89M 199M 2.92M 19.8M 7.71M 101M 7.85M 7.68M 333M |
| Net income | -14.76M -12.65M -11.85M -10.83M -20.43M -1.41B -20.64M -140M -54.43M -710M -55.43M -54.23M -2.35B | -29.99M -25.7M -24.08M -21.99M -41.51M -2.86B -41.92M -284M -111M -1.44B -113M -110M -4.78B |
| Net Debt | -45.25M -38.78M -36.33M -33.19M -62.64M -4.31B -63.25M -429M -167M -2.18B -170M -166M -7.21B | -40.9M -35.05M -32.84M -30M -56.61M -3.9B -57.17M -387M -151M -1.97B -154M -150M -6.52B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25/08/26 | A$0.5100 | +0.99% | 430,600 |
| 24/08/26 | A$0.5050 | +3.06% | 364,792 |
| 21/08/26 | A$0.4900 | -2.00% | 767,057 |
| 20/08/26 | A$0.5000 | -0.99% | 1,133,913 |
| 19/08/26 | A$0.5050 | +1.00% | 334,345 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ATH Stock
Select your edition
All financial news and data tailored to specific country editions
